News
MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...
Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...
Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.
Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...
5h
TipRanks on MSNNeuroSense Reports Long-Term Safety of PrimeC in ALS Study
The latest update is out from Neurosense Therapeutics Ltd. ( ($NRSN) ). As of August 20, 2025, NeuroSense Therapeutics Ltd. reported that ...
The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.
SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...
In a recent study, scientists successfully decoded not only the words people tried to say but the words they merely imagined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results